Clinical Outcomes of Concomitant Use of Proton Pump Inhibitors and Dual Antiplatelet Therapy: A Systematic Review and Meta-Analysis
Conclusion: The use of PPIs was associated with a reduced risk of GI bleeding in patients treated with DAPT after percutaneous coronary intervention or acute coronary syndrome. There was no clear evidence of an association between the use of PPIs and adverse cardiovascular events.Clinical Trial Registration: identifier [CRD42020190315]
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Angioplasty | Bleeding | Cardiology | Cardiovascular | Clinical Trials | Clopidogrel | Coronary Angioplasty | Drugs & Pharmacology | Gastroenterology | Heart | Heart Attack | Percutaneous Coronary Intervention | Plavix | Proton Pump Inhibitors PPIs | Statistics | Study